Ligand validation:5FQD

LVY: S-Lenalidomide

LVY is a Ligand Of Interest in 5FQD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FQD_LVY_B_1438	74%	13%	0.15	0.98	1.26	2.62	1	13	1	0	100%	1
5FQD_LVY_E_1438	33%	17%	0.251	0.933	1.42	2.17	2	11	3	0	100%	1
4TZ4_LVY_C_502	58%	9%	0.188	0.967	1.73	2.7	5	10	0	0	100%	1
4V30_LVY_B_151	90%	2%	0.079	0.961	2.7	4.23	5	12	0	0	100%	1
4CI2_LVY_B_1429	60%	30%	0.184	0.97	0.86	1.89	-	6	0	0	100%	1
8RQA_LVY_A_501	48%	64%	0.123	0.864	0.45	0.91	-	2	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.